Skip to search formSkip to main contentSkip to account menu

trecadrine

Known as: (1-((2-(10,11-dihydro-5H-dibenzo(a,d)cyclohepten-5-ylidene)ethyl)methylamino)ethy)benzyl alcohol 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Benzyl Alcohols

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2003
2003
Effects of a β3-adrenergic agonist on the immune response in diet-induced (cafeteria) obese animals
Molecules with affinity for β3-adrenoceptors are not only effective anti-obesity agents in rodent models, but may play a role in… 
2002
2002
Effects of Trecadrine, a beta3-adrenergic agonist, on leptin secretion, glucose and lipid metabolism in isolated rat adipocytes.
OBJECTIVE Leptin, a hormone produced in adipocytes, is a key signal in the regulation of food intake and energy expenditure. Beta… 
2002
2002
Effects of a beta3-adrenergic agonist on glucose uptake and leptin expression and secretion in cultured adipocytes from lean and overweight (cafeteria) rats.
The increase in body and white adipose tissue weights induced by a high-fat diet were prevented by treatment with the beta3… 
Highly Cited
2000
Highly Cited
2000
Up-regulation of muscle UCP2 gene expression by a new β3-adrenoceptor agonist, trecadrine, in obese (cafeteria) rodents, but down-regulation in lean animals
OBJECTIVE: The anti-obesity properties of a new β3-adrenergic agonist (Trecadrine) were examined in a diet-induced obesity model… 
2000
2000
Effects of the oral administration of a beta3-adrenergic agonist on lipid metabolism in alloxan-diabetic rats.
Previous studies have reported that beta3-adrenergic agonists regulate plasma glucose, triglycerides and free fatty acids in… 
1999
1999
A b3‐adrenergic agonist increases muscle GLUT1/GLUT4 ratio, and regulates liver glucose utilization in diabetic rats*
Aim: Previous studies have reported that β3‐adrenergic agonists reduce plasma glucose levels in situations of hyperglycaemia and… 
1999
1999
Hypolipidemic properties of a diphenyl-methylen-ethylamine derivative with affinity for beta 3-adrenoceptors in a model of hypercholesterolemia.
1999
1999
Effect of a beta3-adrenergic agonist on liver glucokinase gene expression in alloxan-diabetic rats.
Beta-adrenergic agonists have been shown to elicit powerful hypoglycemic effects when administered to different animal models of… 
1997
1997
Effects of Trecadrine, a β3‐Adrenergic Agonist, on Intestinal Absorption of d‐Galactose and Disaccharidase Activities in Three Physiopathological Models
Impairments in intestinal absorptive and digestive processes have been described in several pathophysiological situations, such… 
1997
1997
Effects on energy utilization of a ß3-adrenergic agonist in rats fed on a cafeteria diet
The antiobesity potential of a new ß3-adrenergic agonist (Trecadrine) was assessed in a cafeteria model of obesity through body… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)